High-dose Extended-Field Irradiation and High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Cervical Cancer With Positive Para-Aortic Lymph Nodes

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1522-1528

  Kim, Young Seok ^a   Kim, Jong Hoon ^a   Ahn, Seung Do ^a   Lee, Sang wook ^a   Shin, Seong Soo ^a   Nam, Joo Hyun ^a   Kim, Young Tak ^a   Kim, Yong Man ^a   Kim, Jong Hyeok ^a   Choi, Eun Kyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Cervical cancer; Chemotherapy; Para aortic lymph node; Radiotherapy

Indexed keywords

ACUTE TOXICITY; CERVICAL CANCER; CERVICAL CANCERS; CERVICAL CARCINOMA; COMPLETE RESPONSE; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITIES; HIGH DOSE; HIGH-DOSE RATE BRACHYTHERAPY; IN-FIELD; LYMPH NODE; PARA-AORTIC LYMPH NODE; PERSISTENT DISEASE; PLATINUM-BASED CHEMOTHERAPY; PRIMARY MASS; SURVIVAL RATE; UP PERIOD;

BODY FLUIDS; CHEMOTHERAPY; ENZYME INHIBITION; PLATINUM; RADIOTHERAPY; TOXICITY;

BLOOD VESSELS;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; COLONY STIMULATING FACTOR; FLUOROURACIL; PACLITAXEL;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; ILEUS; KIDNEY DYSFUNCTION; LYMPH NODE METASTASIS; NAUSEA; NEUTROPENIA; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RECTOVAGINAL FISTULA; TREATMENT FAILURE; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; VOMITING;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AORTA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; MIDDLE AGED; PACLITAXEL; RADIOTHERAPY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 67651094198     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.024     Document Type: Article

References (31)

1. Sakuragi N., Satoh C., Takeda N., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 (1999) 1547-1554
2. Stehman F.B., Bundy B.N., Hanjani P., et al. Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes. Surg Gynecol Obstet 165 (1987) 503-506
3. Berman M.L., Keys H., Creasman W., et al. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 19 (1984) 8-16
4. Stehman F.B., Bundy B.N., DiSaia P.J., et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785
5. Toita T., Nakano M., Higashi M., et al. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy. Int J Radiat Oncol Biol Phys 33 (1995) 843-849
6. Grigsby P.W., Perez C.A., Chao K.S., et al. Radiation therapy for carcinoma of the cervix with biopsy-proven positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 49 (2001) 733-738
7. Lovecchio J.L., Averette H.E., Donato D., et al. 5-Year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. Gynecol Oncol 34 (1989) 43-45
8. Nori D., Valentine E., and Hilaris B.S. The role of paraaortic node irradiation in the treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 11 (1985) 1469-1473
9. Chung Y.L., Jian J.J., Cheng S.H., et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: A phase I/II study. Gynecol Oncol 97 (2005) 126-135
10. Grigsby P.W., Heydon K., Mutch D.G., et al. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51 (2001) 982-987
11. Malfetano J.H., and Keys H. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases. Gynecol Oncol 42 (1991) 44-47
12. Small Jr. W., Winter K., Levenback C., et al. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: Results of arm 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 68 (2007) 1081-1087
13. Uno T., Mitsuhashi A., Isobe K., et al. Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer 18 (2008) 80-84
14. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy-A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42 (1998) 1015-1023
15. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
16. Gerszten K., Colonello K., Heron D.E., et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol 102 (2006) 182-188
17. Salama J.K., Mundt A.J., Roeske J., et al. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys 65 (2006) 1170-1176
18. Rotman M., Pajak T.F., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: Ten-year treatment results of RTOG 79-20. JAMA 274 (1995) 387-393
19. Stryker J.A., and Mortel R. Survival following extended field irradiation in carcinoma of cervix metastatic to para-aortic lymph nodes. Gynecol Oncol 79 (2000) 399-405
20. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
21. Hellman S. Oligometastases. J Clin Oncol 13 (1995) 8-10
22. Fyles A.W., Pintilie M., Kirkbride P., et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis. Radiother Oncol 35 (1995) 107-117
23. Sood B.M., Gorla G.R., Garg M., et al. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: Clinical experience with and without concomitant chemotherapy. Cancer 97 (2003) 1781-1788
24. Chen S.W., Liang J.A., Hung Y.C., et al. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: A control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys 66 (2006) 1370-1377
25. Strauss H.G., Kuhnt T., Laban C., et al. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study. Strahlenther Onkol 178 (2002) 378-385
26. Cosin J.A., Fowler J.M., Chen M.D., et al. Pretreatment surgical staging of patients with cervical carcinoma: The case for lymph node debulking. Cancer 82 (1998) 2241-2248
27. Kim P.Y., Monk B.J., Chabra S., et al. Cervical cancer with paraaortic metastases: Significance of residual paraaortic disease after surgical staging. Gynecol Oncol 69 (1998) 243-247
28. Vergote I., Amant F., Berteloot P., et al. Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer. Int J Gynecol Cancer 12 (2002) 22-26
29. Choi H.J., Kim S.H., Seo S.S., et al. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 187 (2006) W538-W543
30. Kim S.H., Kim S.C., Choi B.I., et al. Uterine cervical carcinoma: Evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190 (1994) 807-811
31. Rose P.G., Adler L.P., Rodriguez M., et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol 17 (1999) 41-45